The American Diabetes Association's 76th Scientific Sessions were held in New Orleans, LA from June 10-14, 2016.
Cardiovascular Risks with Insulins
Investigators examined cardiovascular risk with the new basal insulin peglispro compared to insulin glargine or NPH in diabetic patients.
Benefits of Continued Cardiorespiratory Fitness
A 20-year study examined the long-term effect of cardiorespiratory fitness on risk of developing prediabetes or diabetes.
Aging and Beta Cell Function
Aging may be beneficial to diabetes patients. Recent findings suggest a cellular aging process may, unexpectedly, enhance insulin secretion.
IRIS Trial Examines CV and Diabetes Risks
A secondary analysis of data from the Insulin Resistance Intervention after Stroke trial (IRIS) examined pioglitazone’s effect on diabetes prevention.
Potential Dual-Hormone Bionic Pancreas
The first at-home study to test the efficacy & safety of a fully automated, dual hormone (glucagon and insulin) bionic pancreas was presented at ADA.
Lifestyle Intervention Program for Type 2 Diabetes
A study tested the impact of intensive lifestyle intervention in low-income African Americans with type 2 diabetes. Results were shared at ADA.
Canagliflozin Plus Metformin in Type 2 Diabetes
Investigators compared initial therapy with canagliflozin plus metformin to metformin monotherapy in drug naïve type 2 diabetes patients.
Reversing Type 2 Diabetes
In this Medical News Minute, Dr. Bobby Lazzara summarizes a study on the effects of a very-low-calorie diet on blood glucose.
Islet Cell Transplants for Type 1 Diabetes
In this Medical News Minute, Dr. Bobby Lazzara examines a phase 3 study of transplanted purified human pancreatic islets in type 1 diabetes patients.
Endo News Roundup: Promising Diabetes Therapies
Three new studies highlight promising diabetes drug treatments to help patients who struggle with severe hyperglycemia.
Interesting Endo: Diabetes Risks and Nephropathy
Our May list of news and research includes studies on type 2 diabetes risks, post-bariatric surgery results, and diabetic nephropathy.
ENDO 2016: Women’s Health – Part 2
To continue our coverage of women’s health from ENDO 2016, we summarize findings on bone mass loss and asthma in polycystic ovary syndrome.
ENDO 2016: Women’s Health – Part 1
In this ENDO 2016 update, we summarize the new scientific statement on compounded bioidentical hormones and report on a device to treat infertility.
By clicking Accept, you agree to become a member of the UBM Medica Community.